nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—NR3C1—type 2 diabetes mellitus	0.86	1	CbGaD
Difluprednate—Macular oedema—Rosiglitazone—type 2 diabetes mellitus	0.00823	0.161	CcSEcCtD
Difluprednate—Macular oedema—Pioglitazone—type 2 diabetes mellitus	0.0069	0.135	CcSEcCtD
Difluprednate—Visual acuity reduced—Rosiglitazone—type 2 diabetes mellitus	0.00338	0.0661	CcSEcCtD
Difluprednate—Pregnancy—Pioglitazone—type 2 diabetes mellitus	0.00297	0.0581	CcSEcCtD
Difluprednate—Visual acuity reduced—Pioglitazone—type 2 diabetes mellitus	0.00283	0.0554	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—HHEX—type 2 diabetes mellitus	0.00245	0.031	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—G6PC—type 2 diabetes mellitus	0.00199	0.0252	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA6—type 2 diabetes mellitus	0.00176	0.0223	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—INSR—type 2 diabetes mellitus	0.00175	0.0222	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—type 2 diabetes mellitus	0.00169	0.0214	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—type 2 diabetes mellitus	0.00169	0.0214	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ABCC8—type 2 diabetes mellitus	0.00162	0.0205	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—type 2 diabetes mellitus	0.00151	0.0191	CbGpPWpGaD
Difluprednate—Weight increased—Linagliptin—type 2 diabetes mellitus	0.0015	0.0293	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00148	0.0187	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.00146	0.0185	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—PCK1—type 2 diabetes mellitus	0.00142	0.0179	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—type 2 diabetes mellitus	0.00138	0.0175	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—NCOA6—type 2 diabetes mellitus	0.00129	0.0162	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—type 2 diabetes mellitus	0.00128	0.0162	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—type 2 diabetes mellitus	0.00123	0.0156	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.00119	0.015	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—type 2 diabetes mellitus	0.00118	0.0149	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—HNF4A—type 2 diabetes mellitus	0.00118	0.0149	CbGpPWpGaD
Difluprednate—Weight increased—Rosiglitazone—type 2 diabetes mellitus	0.00115	0.0224	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—type 2 diabetes mellitus	0.00112	0.0141	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—type 2 diabetes mellitus	0.00107	0.0135	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—type 2 diabetes mellitus	0.00105	0.0132	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—type 2 diabetes mellitus	0.00105	0.0132	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—type 2 diabetes mellitus	0.00102	0.0129	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—HNF1B—type 2 diabetes mellitus	0.000975	0.0123	CbGpPWpGaD
Difluprednate—Weight increased—Pioglitazone—type 2 diabetes mellitus	0.000962	0.0188	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.000955	0.0121	CbGpPWpGaD
Difluprednate—Weight increased—Glimepiride—type 2 diabetes mellitus	0.000937	0.0183	CcSEcCtD
Difluprednate—Weight increased—Sitagliptin—type 2 diabetes mellitus	0.000934	0.0183	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—HNF4A—type 2 diabetes mellitus	0.00093	0.0118	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—type 2 diabetes mellitus	0.000929	0.0117	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—LEP—type 2 diabetes mellitus	0.000909	0.0115	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—RETN—type 2 diabetes mellitus	0.000901	0.0114	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000876	0.0111	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000859	0.0109	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.000816	0.0103	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.000814	0.0103	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000811	0.0102	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.000791	0.01	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000786	0.00993	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000779	0.00984	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.000775	0.00979	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.000766	0.00968	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.000748	0.00945	CbGpPWpGaD
Difluprednate—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000736	0.0144	CcSEcCtD
Difluprednate—Vision blurred—Glipizide—type 2 diabetes mellitus	0.000725	0.0142	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000724	0.00915	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000724	0.00915	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.000712	0.009	CbGpPWpGaD
Difluprednate—Weight increased—Gliclazide—type 2 diabetes mellitus	0.000694	0.0136	CcSEcCtD
Difluprednate—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000676	0.0132	CcSEcCtD
Difluprednate—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.000674	0.0132	CcSEcCtD
Difluprednate—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000669	0.0131	CcSEcCtD
Difluprednate—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000669	0.0131	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000665	0.00841	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000657	0.00831	CbGpPWpGaD
Difluprednate—Headache—Tolbutamide—type 2 diabetes mellitus	0.000651	0.0127	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000645	0.00815	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000643	0.00812	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000632	0.00798	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000625	0.0079	CbGpPWpGaD
Difluprednate—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00062	0.0121	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000618	0.00782	CbGpPWpGaD
Difluprednate—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00061	0.0119	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000598	0.00756	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000597	0.00754	CbGpPWpGaD
Difluprednate—Headache—Tolazamide—type 2 diabetes mellitus	0.000593	0.0116	CcSEcCtD
Difluprednate—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000593	0.0116	CcSEcCtD
Difluprednate—Headache—Linagliptin—type 2 diabetes mellitus	0.000587	0.0115	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000572	0.00723	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.00057	0.00721	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000564	0.00713	CbGpPWpGaD
Difluprednate—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000558	0.0109	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000557	0.00704	CbGpPWpGaD
Difluprednate—Weight increased—Irbesartan—type 2 diabetes mellitus	0.000548	0.0107	CcSEcCtD
Difluprednate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000537	0.0105	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000516	0.00652	CbGpPWpGaD
Difluprednate—Weight increased—Losartan—type 2 diabetes mellitus	0.000516	0.0101	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000511	0.00646	CbGpPWpGaD
Difluprednate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000507	0.00992	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000505	0.00638	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000489	0.00618	CbGpPWpGaD
Difluprednate—Headache—Repaglinide—type 2 diabetes mellitus	0.000475	0.00929	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.00047	0.00595	CbGpPWpGaD
Difluprednate—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00046	0.009	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.00046	0.00581	CbGpPWpGaD
Difluprednate—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000455	0.00889	CcSEcCtD
Difluprednate—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000449	0.00878	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000447	0.00565	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000446	0.00563	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000445	0.00563	CbGpPWpGaD
Difluprednate—Pruritus—Glipizide—type 2 diabetes mellitus	0.000444	0.00868	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000443	0.00559	CbGpPWpGaD
Difluprednate—Weight increased—Ramipril—type 2 diabetes mellitus	0.000442	0.00865	CcSEcCtD
Difluprednate—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000437	0.0455	CrCbGaD
Difluprednate—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000437	0.0455	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000432	0.00545	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.00042	0.00531	CbGpPWpGaD
Difluprednate—Vision blurred—Metformin—type 2 diabetes mellitus	0.000419	0.0082	CcSEcCtD
Difluprednate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000414	0.0081	CcSEcCtD
Difluprednate—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000413	0.0431	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.00041	0.00519	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000409	0.00517	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000404	0.00511	CbGpPWpGaD
Difluprednate—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000403	0.042	CrCbGaD
Difluprednate—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000395	0.00773	CcSEcCtD
Difluprednate—Headache—Glipizide—type 2 diabetes mellitus	0.000393	0.00769	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000392	0.00496	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000385	0.00486	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00038	0.00481	CbGpPWpGaD
Difluprednate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000377	0.00737	CcSEcCtD
Difluprednate—Vision blurred—Losartan—type 2 diabetes mellitus	0.000372	0.00728	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000372	0.0047	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000371	0.00468	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000369	0.00466	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000367	0.00464	CbGpPWpGaD
Difluprednate—Headache—Glimepiride—type 2 diabetes mellitus	0.000367	0.00718	CcSEcCtD
Difluprednate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000366	0.00715	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000353	0.00446	CbGpPWpGaD
Difluprednate—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000347	0.0362	CrCbGaD
Difluprednate—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000343	0.00433	CbGpPWpGaD
Difluprednate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000342	0.00668	CcSEcCtD
Difluprednate—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000341	0.0356	CrCbGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000339	0.00429	CbGpPWpGaD
Difluprednate—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000336	0.035	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000334	0.00422	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000332	0.0042	CbGpPWpGaD
Difluprednate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000331	0.00647	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000328	0.00414	CbGpPWpGaD
Difluprednate—Megestrol acetate—NR3C1—type 2 diabetes mellitus	0.000324	0.0338	CrCbGaD
Difluprednate—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000317	0.0331	CrCbGaD
Difluprednate—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.000311	0.0324	CrCbGaD
Difluprednate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000307	0.006	CcSEcCtD
Difluprednate—Headache—Glyburide—type 2 diabetes mellitus	0.000303	0.00592	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000303	0.00382	CbGpPWpGaD
Difluprednate—Mometasone—NR3C1—type 2 diabetes mellitus	0.000302	0.0315	CrCbGaD
Difluprednate—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000302	0.00381	CbGpPWpGaD
Difluprednate—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000298	0.0311	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000298	0.00377	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000287	0.00363	CbGpPWpGaD
Difluprednate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000282	0.00551	CcSEcCtD
Difluprednate—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000281	0.0293	CrCbGaD
Difluprednate—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000281	0.0293	CrCbGaD
Difluprednate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000279	0.00545	CcSEcCtD
Difluprednate—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000273	0.0285	CrCbGaD
Difluprednate—Headache—Gliclazide—type 2 diabetes mellitus	0.000272	0.00531	CcSEcCtD
Difluprednate—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000266	0.0278	CrCbGaD
Difluprednate—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000266	0.0278	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000266	0.00336	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000264	0.00333	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000264	0.00333	CbGpPWpGaD
Difluprednate—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000263	0.0274	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000262	0.00331	CbGpPWpGaD
Difluprednate—Pruritus—Metformin—type 2 diabetes mellitus	0.000257	0.00502	CcSEcCtD
Difluprednate—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000257	0.0267	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000251	0.00318	CbGpPWpGaD
Difluprednate—Headache—Valsartan—type 2 diabetes mellitus	0.00025	0.00488	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000249	0.00315	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000248	0.00314	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000248	0.00314	CbGpPWpGaD
Difluprednate—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000248	0.0259	CrCbGaD
Difluprednate—Headache—Orlistat—type 2 diabetes mellitus	0.000247	0.00482	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000245	0.0031	CbGpPWpGaD
Difluprednate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000242	0.00474	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	0.000239	0.00302	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000238	0.0248	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000236	0.00298	CbGpPWpGaD
Difluprednate—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000233	0.0243	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	0.000231	0.00292	CbGpPWpGaD
Difluprednate—Pruritus—Losartan—type 2 diabetes mellitus	0.000228	0.00446	CcSEcCtD
Difluprednate—Headache—Metformin—type 2 diabetes mellitus	0.000227	0.00445	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	0.000225	0.00284	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	0.000224	0.00283	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	0.000224	0.00283	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	0.000224	0.00283	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	0.000219	0.00277	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	0.000216	0.00273	CbGpPWpGaD
Difluprednate—Headache—Irbesartan—type 2 diabetes mellitus	0.000215	0.0042	CcSEcCtD
Difluprednate—Triamcinolone—NR3C1—type 2 diabetes mellitus	0.000209	0.0218	CrCbGaD
Difluprednate—Headache—Losartan—type 2 diabetes mellitus	0.000202	0.00395	CcSEcCtD
Difluprednate—Dexamethasone—NOS2—type 2 diabetes mellitus	0.000197	0.0205	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	0.000196	0.00247	CbGpPWpGaD
Difluprednate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000196	0.00382	CcSEcCtD
Difluprednate—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	0.000195	0.0203	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000194	0.00245	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	0.000191	0.00242	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	0.000189	0.00238	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	0.000187	0.00237	CbGpPWpGaD
Difluprednate—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	0.000187	0.0195	CrCbGaD
Difluprednate—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	0.000183	0.00231	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	0.000181	0.00229	CbGpPWpGaD
Difluprednate—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	0.00018	0.0188	CrCbGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	0.00018	0.00227	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	0.000178	0.00225	CbGpPWpGaD
Difluprednate—Headache—Ramipril—type 2 diabetes mellitus	0.000173	0.00339	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	0.000172	0.00218	CbGpPWpGaD
Difluprednate—Betamethasone—NR3C1—type 2 diabetes mellitus	0.000171	0.0179	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000161	0.00203	CbGpPWpGaD
Difluprednate—Flunisolide—CYP3A4—type 2 diabetes mellitus	0.000154	0.0161	CrCbGaD
Difluprednate—Paramethasone—CYP3A4—type 2 diabetes mellitus	0.000152	0.0159	CrCbGaD
Difluprednate—Fluorometholone—CYP3A4—type 2 diabetes mellitus	0.000149	0.0155	CrCbGaD
Difluprednate—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	0.000144	0.015	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000138	0.00174	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	0.000134	0.0017	CbGpPWpGaD
Difluprednate—Dexamethasone—ABCC2—type 2 diabetes mellitus	0.000131	0.0136	CrCbGaD
Difluprednate—Triamcinolone—CYP3A4—type 2 diabetes mellitus	0.000121	0.0126	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000121	0.00152	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000119	0.00151	CbGpPWpGaD
Difluprednate—Triamcinolone—PTGS2—type 2 diabetes mellitus	0.000119	0.0124	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	0.000118	0.0015	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	0.000114	0.00143	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000113	0.00143	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	0.000111	0.00141	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	0.00011	0.00139	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	0.000109	0.00138	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	0.000109	0.00137	CbGpPWpGaD
Difluprednate—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	0.000108	0.0113	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	0.000103	0.0013	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000102	0.00129	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	0.000101	0.00128	CbGpPWpGaD
Difluprednate—Dexamethasone—NR3C1—type 2 diabetes mellitus	9.96e-05	0.0104	CrCbGaD
Difluprednate—Betamethasone—CYP3A4—type 2 diabetes mellitus	9.93e-05	0.0104	CrCbGaD
Difluprednate—Betamethasone—PTGS2—type 2 diabetes mellitus	9.72e-05	0.0101	CrCbGaD
Difluprednate—Dexamethasone—CYP2E1—type 2 diabetes mellitus	9.17e-05	0.00956	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	8.77e-05	0.00111	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	8.44e-05	0.00107	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	8.19e-05	0.00103	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	7.74e-05	0.000978	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	7.08e-05	0.000895	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	6.98e-05	0.000882	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	6.76e-05	0.000855	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	6.76e-05	0.000855	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	6.64e-05	0.000839	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	6.29e-05	0.000794	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP3A4—type 2 diabetes mellitus	5.78e-05	0.00602	CrCbGaD
Difluprednate—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	5.75e-05	0.000727	CbGpPWpGaD
Difluprednate—Dexamethasone—PTGS2—type 2 diabetes mellitus	5.65e-05	0.0059	CrCbGaD
Difluprednate—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	5.36e-05	0.000678	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	4.94e-05	0.000625	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	4.89e-05	0.000618	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	4.32e-05	0.000546	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	4.06e-05	0.000514	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	3.36e-05	0.000425	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	3.03e-05	0.000382	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	1.33e-05	0.000168	CbGpPWpGaD
